PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsEuroGenerics
EuroGenerics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
QutavinaTeriparatide2020-08-272025
Osteoporosis
,
Postmenopausal osteoporosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fluzone
pneumonia
,
pneumococcal pneumonia
,
haemophilus influenzae
,
streptococcus pneumoniae
,
virus diseases
,
chronic obstructive pulmonary disease
,
respiration disorders
,
arthralgia
,
dengue
,
rotavirus infections
,
haemophilus infections
,
neisseria meningitidis
,
respiratory syncytial virus infections
,
influenza in birds
,
herpes zoster
,
tetanus
,
diphtheria
,
meningococcal infections
,
respiratory tract diseases
,
hepatitis b
,
poliomyelitis
,
pneumococcal infections
,
orthomyxoviridae infections
,
gram-negative bacterial infections
,
whooping cough
,
hepatitis
,
herpes simplex
,
hepatitis a
,
covid-19
,
human influenza
,
haemophilus influenzae type b
,
infections
,
h1n1 subtype influenza a virus
,
common cold
,
healthy volunteers/patients
,
hiv infections
,
otitis media
,
respiratory tract infections
,
communicable diseases
,
disease progression
,
sinusitis
,
asthma
,
bronchitis
,
bronchial spasm
,
multiple sclerosis
,
sclerosis
,
narcolepsy
,
myositis
,
fever
,
infectious encephalitis
,
immunologic tests
,
malaria
,
meningitis
,
otitis
,
emergencies
,
drug-related side effects and adverse reactions
Flumist
human influenza
Flucelvax
paramyxoviridae infections
,
influenza in birds
,
covid-19
,
multiple sclerosis
,
neoplasms
,
virus diseases
,
dengue virus
,
orthomyxoviridae
,
infections
,
communicable diseases
,
infectious myxomatosis
,
h1n1 subtype influenza a virus
,
whooping cough
,
tetanus
,
diphtheria
,
poliomyelitis
,
obesity
,
dengue
,
severe dengue
,
tetany
,
haemophilus infections
,
haemophilus influenzae type b
,
meningococcal infections
,
flavivirus infections
,
yellow fever
,
inactivated vaccines
,
morbid obesity
,
human influenza
,
orthomyxoviridae infections
,
healthy volunteers/patients
,
pneumonia
,
heart failure
,
stroke
,
myocardial infarction
,
infarction
,
multiple myeloma
,
plasma cell neoplasms
,
plasmacytoma
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
,
pregnancy
,
immune system diseases
,
pregnancy complications
,
micronutrients
,
toxicological phenomena
,
otitis media
,
respiratory syncytial virus infections
,
bronchiolitis
,
otitis
,
only child
,
atrial fibrillation
,
cardiovascular diseases
,
coronary disease
,
cardiac arrhythmias
,
heart arrest
,
emergencies
,
diabetes mellitus
,
respiratory tract infections
,
inferior wall myocardial infarction
,
severe acute respiratory syndrome
,
behavior and behavior mechanisms
,
immunization
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use